| 000 | 01814 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514003020.0 | ||
| 264 | 0 | _c20010830 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a0022-3077 | ||
| 024 | 7 |
_a10.1152/jn.2001.86.1.40 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorisset, V | |
| 245 | 0 | 0 |
_aCannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord. _h[electronic resource] |
| 260 |
_bJournal of neurophysiology _cJul 2001 |
||
| 300 |
_a40-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnalgesics _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArachidonic Acids _xpharmacology |
| 650 | 0 | 4 | _aBenzoxazines |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aCannabinoids _xpharmacology |
| 650 | 0 | 4 |
_aCapsaicin _xpharmacology |
| 650 | 0 | 4 | _aEndocannabinoids |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Agonists _xpharmacology |
| 650 | 0 | 4 |
_aExcitatory Postsynaptic Potentials _xdrug effects |
| 650 | 0 | 4 |
_aGlutamic Acid _xphysiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMorpholines _xpharmacology |
| 650 | 0 | 4 |
_aNaphthalenes _xpharmacology |
| 650 | 0 | 4 |
_aNerve Fibers _xdrug effects |
| 650 | 0 | 4 |
_aNeural Inhibition _xdrug effects |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 | _aPatch-Clamp Techniques |
| 650 | 0 | 4 | _aPolyunsaturated Alkamides |
| 650 | 0 | 4 |
_aPresynaptic Terminals _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSubstantia Gelatinosa _xcytology |
| 650 | 0 | 4 |
_aalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid _xpharmacology |
| 700 | 1 | _aUrban, L | |
| 773 | 0 |
_tJournal of neurophysiology _gvol. 86 _gno. 1 _gp. 40-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1152/jn.2001.86.1.40 _zAvailable from publisher's website |
| 999 |
_c11360725 _d11360725 |
||